Document Detail


Four patients with Sillence type I osteogenesis imperfecta and mild bone fragility, complicated by left ventricular cardiac valvular disease and cardiac tissue fragility caused by type I collagen mutations.
MedLine Citation:
PMID:  24311407     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Osteogenesis imperfecta (OI) type I is a hereditary disorder of connective tissue (HDCT) characterized by blue or gray sclerae, variable short stature, dentinogenesis imperfecta, hearing loss, and recurrent fractures from infancy. We present four examples of OI type I complicated by valvular heart disease and associated with tissue fragility. The diagnosis of a type I collagen disorder was confirmed by abnormal COL1A1 or COL1A2 gene sequencing. One patient was investigated with electrophoresis of collagens from cultured skin fibroblasts, showing structurally abnormal collagen type I, skin biopsy showed unusual histology and abnormal collagen fibril ultra-structure at electron microscopy. The combined clinical, surgical, histological, ultra-structural, and molecular genetic data suggest the type I collagen defect as contributory to cardiac valvular disease. The degree of tissue fragility experienced at cardiac surgery in these individuals, also reported in a small number of similar case reports, suggests that patients with OI type I need careful pre-operative assessment and consideration of the risks and benefits of cardiac surgery. © 2013 Wiley Periodicals, Inc.
Authors:
Anthony M Vandersteen; Allan M Lund; David J P Ferguson; Philip Sawle; Rebecca C Pollitt; Susan E Holder; Emma Wakeling; Neil Moat; F Michael Pope
Related Documents :
23274577 - Incidence of periprocedural myocardial infarction and cardiac biomarker testing after p...
22955207 - Alarm!!! a ufo inside the heart.
23628007 - Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction.
23314057 - Mutations in the notch pathway regulator mib1 cause left ventricular noncompaction card...
22027687 - The three year follow-up of the randomised "all-comers" trial of a biodegradable polyme...
8841007 - New stent technologies.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-12-5
Journal Detail:
Title:  American journal of medical genetics. Part A     Volume:  -     ISSN:  1552-4833     ISO Abbreviation:  Am. J. Med. Genet. A     Publication Date:  2013 Dec 
Date Detail:
Created Date:  2013-12-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101235741     Medline TA:  Am J Med Genet A     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Wiley Periodicals, Inc.
Affiliation:
Ehlers-Danlos Syndrome National Diagnostic Service, North West London Hospitals NHS Trust, Harrow, Middlesex, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hydrogen-Bonding in Aminocatalysis: From Proline and Beyond.
Next Document:  Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression.